With CRISPR-Cas9 technology, generation of genome-edited human pluripotent cell lines has increased. This seminar discusses critical quality control aspects for robust hPSC cultures, exemplified with disease modeling methods using cerebral organoids.
To view the webinar, please complete the form, or sign in to your account.